A contract for over 100,000 monkeypox vaccines

BRUSSELS | The European Commission and the Danish laboratory Bavarian Nordic announced on Tuesday that they have signed an agreement for the purchase of more than 100,000 doses of monkeypox vaccines that have been detected in 19 Member States, as well as Norway and Iceland.

• Also read: Sex tourism during the Canadian Grand Prix: fears of the spread of monkeypox

• Also read: The number of monkeypox cases in the country could increase in the coming days

• Also read: Symptoms can be difficult to identify, US authorities warn

The agreement includes the delivery of 109,090 doses of vaccine on behalf of European countries, the Commission said in a press release. It is inspired by the group purchases of anti-COVID vaccines, but concerns much smaller quantities.

Marketed under the names Imvanex in Europe, Jynneos in the United States and Imvamune in Canada, it is a 3rd generation (non-replicating live, i.e. adult.

The European Medicines Regulatory Agency (EMA) announced in early June that it was in talks with Bavarian Nordic to potentially expand its use against monkeypox.

Around 900 cases have been reported in European countries since May 18, according to the commission. The contract amount was not disclosed.

This disease is mostly benign, but its spread outside the endemic areas, mainly in Europe, remains a concern. It initially causes a high fever and quickly develops into a rash with scabs.

The European Center for Disease Control and Prevention has recommended early vaccination after exposure to prevent the disease or make its development less severe, reminds Brussels.

Vaccines purchased on behalf of the new Hera health agency (established in the wake of the COVID-19 pandemic) will be made available to the Twenty-Seven plus Norway and Iceland, with first deliveries by the end of June for the focus countries then deliveries between July and mid-August, specifies the Commission.

“This is the first time that we have used the European budget through the EU4Health program to respond to a health emergency (…) It is extremely tangible evidence of a collective response enabled by the Union of Health” which started to materialize gradually with the COVID-19 pandemic, welcomed EU Health Commissioner Stella Kyriakides.

According to the WHO, as of June 8, the number of confirmed cases of this disease worldwide was nearly 1,300 in non-endemic countries.

The less dangerous cousin of smallpox, which was eradicated forty years ago, is endemic to 11 countries in West and Central Africa.

Leave a Comment